phenoxybenzamine has been researched along with sk&f-38393 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, SG; Balmforth, AJ; Bryson, SE; Hall, AS | 1 |
| Rossi, NF | 1 |
2 other study(ies) available for phenoxybenzamine and sk&f-38393
| Article | Year |
|---|---|
Phenoxybenzamine mediated inhibition of the vascular dopamine D1 receptor.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cells, Cultured; Cyclic AMP; Dopamine; Isoproterenol; Male; Muscle, Smooth, Vascular; Phenoxybenzamine; Rats; Rats, Wistar; Receptors, Dopamine D1 | 1993 |
Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Angiotensin II; Animals; Apomorphine; Arginine Vasopressin; Benzazepines; Domperidone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Hypothalamo-Hypophyseal System; Kinetics; Male; Models, Neurological; Organ Culture Techniques; Phenoxybenzamine; Prazosin; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 1998 |